CTRI/2018/03/012679尚未招募2 期
An open label prospective phase II clinical study to evaluate efficacy and safety of panchendriyavardhan tail in the insomnia
Aushadhi Bhavan0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Healthy volunteers suffering from insomnia and willing to give written informed consent
排除标准
- •Volunteers with chronic illness
研究者
相似试验
进行中（未招募）
1 期
En åben fase II undersøgelse af sikkerhed, tolerabilitet, højeste tolerable dosis og anti-tumor effekt af SCO-101 i kombination med FOLFIRI som en sikker og effektiv behandling af patienter med udbredt kolorektalkræft, der har udviklet behandlingsresistens overfor behandling med FOLFIRIMetastatic or advanced colorectal cancer (mCRC) with acquired resistance to chemotherapyMedDRA version: 27.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2019-003779-20-DKScandion Oncology A/S79
进行中（未招募）
1 期
An open phase II study of safety, tolerability, highest tolerable dose and anti-tumor effect of SCO-101 in combination with FOLFIRI as a safe and effective treatment of patients with widespread colorectal cancer who has developed treatment resistance to treatment with FOLFIRIEUCTR2019-003779-20-ESScandion Oncology A/S35
进行中（未招募）
1 期
An open phase II study of safety, tolerability, highest tolerable dose and anti-tumor effect of SCO-101 in combination with FOLFIRI as a safe and effective treatment of patients with widespread colorectal cancer who has developed treatment resistance to treatment with FOLFIRIEUCTR2019-003779-20-DEScandion Oncology A/S35
进行中（未招募）
不适用
Prospective, randomized, open label phase II study to assess efficacy and safety of Macugen® (pegaptanib 0.3 mg intravitreal injections) plus panretinal photocoagulation (PRP) and PRP (monotherapy) in the treatment of patients with high risk proliferative diabetic retinopathy. -Proliferative Diabetic Retinopathy.MedDRA version: 12.0Level: LLTClassification code 10036857Term: Proliferative diabetic retinopathyEUCTR2009-016760-36-PTAIBILI
已完成
2 期
To evaluate the safety and efficacy of Arnophyte Cream in subjects with HerpesCTRI/2018/01/011171Piramal Enterprises Limited40